# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the developmen...
New Alliance™ iS Bio High Performance Liquid Chromatography (HPLC) System helps biopharmaceutical QC laboratories boost effic...
Evercore ISI Group analyst Vijay Kumar maintains Waters (NYSE:WAT) with a In-Line and raises the price target from $320 to $...
Goldman Sachs analysts identified a substantial opportunity in the manufacturing sector for new obesity therapeutics, as demand...
Waters Corporation beats Q4 earnings estimates, outlining mixed regional sales performance and cautious outlook for 2024.